Alexandra Lucas

2.9k total citations · 1 hit paper
75 papers, 2.2k citations indexed

About

Alexandra Lucas is a scholar working on Immunology, Cancer Research and Surgery. According to data from OpenAlex, Alexandra Lucas has authored 75 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Immunology, 21 papers in Cancer Research and 19 papers in Surgery. Recurrent topics in Alexandra Lucas's work include Protease and Inhibitor Mechanisms (18 papers), Blood Coagulation and Thrombosis Mechanisms (12 papers) and Virus-based gene therapy research (11 papers). Alexandra Lucas is often cited by papers focused on Protease and Inhibitor Mechanisms (18 papers), Blood Coagulation and Thrombosis Mechanisms (12 papers) and Virus-based gene therapy research (11 papers). Alexandra Lucas collaborates with scholars based in United States, Canada and China. Alexandra Lucas's co-authors include Grant McFadden, Cheryl Cameron, John W. Barrett, Bruce T. Seet, Steven H. Nazarian, Craig R. Brunetti, James B. Johnston, Helen Everett, Joanne Macen and Kathryn Graham and has published in prestigious journals such as Cell, Journal of Biological Chemistry and Circulation.

In The Last Decade

Alexandra Lucas

71 papers receiving 2.1k citations

Hit Papers

Poxviruses and Immune Evasion 2003 2026 2010 2018 2003 100 200 300 400 500

Peers

Alexandra Lucas
Lynn R. Budgeon United States
Luise Florin Germany
Michelle A. Ozbun United States
Linda Andrus United States
Jason P. Gardner United States
James W. Tung United States
Andrew J. Syder United States
Lynn R. Budgeon United States
Alexandra Lucas
Citations per year, relative to Alexandra Lucas Alexandra Lucas (= 1×) peers Lynn R. Budgeon

Countries citing papers authored by Alexandra Lucas

Since Specialization
Citations

This map shows the geographic impact of Alexandra Lucas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexandra Lucas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexandra Lucas more than expected).

Fields of papers citing papers by Alexandra Lucas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alexandra Lucas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexandra Lucas. The network helps show where Alexandra Lucas may publish in the future.

Co-authorship network of co-authors of Alexandra Lucas

This figure shows the co-authorship network connecting the top 25 collaborators of Alexandra Lucas. A scholar is included among the top collaborators of Alexandra Lucas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alexandra Lucas. Alexandra Lucas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gao, Lei, Bofang Wang, Yang Yu, et al.. (2024). FXa-mediated PAR-2 promotes the efficacy of immunotherapy for hepatocellular carcinoma through immune escape and anoikis resistance by inducing PD-L1 transcription. Journal for ImmunoTherapy of Cancer. 12(7). e009565–e009565. 6 indexed citations
2.
Munuswamy‐Ramanujam, Ganesh, Alan Rawls, Jeanne Wilson‐Rawls, et al.. (2024). Urokinase-Type Plasminogen Activator Receptor (uPAR) in Inflammation and Disease: A Unique Inflammatory Pathway Activator. Biomedicines. 12(6). 1167–1167. 19 indexed citations
3.
Christie, John D., Nicole Appel, Liqiang Zhang, et al.. (2022). Systemic Delivery of mLIGHT-Armed Myxoma Virus Is Therapeutic for Later-Stage Syngeneic Murine Lung Metastatic Osteosarcoma. Cancers. 14(2). 337–337. 8 indexed citations
4.
Yeh, Steve T., Sriram Ambadapadi, Jacquelyn Kilbourne, et al.. (2022). Virus-Derived Chemokine Modulating Protein Pre-Treatment Blocks Chemokine–Glycosaminoglycan Interactions and Significantly Reduces Transplant Immune Damage. Pathogens. 11(5). 588–588. 1 indexed citations
5.
Yaron, Jordan R., Liqiang Zhang, Shahar Keinan, et al.. (2020). Deriving Immune-Modulating Peptides from Viral Serine Protease Inhibitors (Serpins). Methods in molecular biology. 2225. 107–123. 1 indexed citations
6.
Shah, Chintan, Yan Gong, Anita Szady, et al.. (2017). Unanticipated Cardiotoxicity Associated with Targeted Anticancer Therapy in Patients with Hematologic Malignancies Patients: Natural History and Risk Factors. Cardiovascular Toxicology. 18(2). 184–191. 10 indexed citations
7.
Kwiecień, Jacek M., et al.. (2017). Loss of Kaiso expression in breast cancer cells prevents intra-vascular invasion in the lung and secondary metastasis. PLoS ONE. 12(9). e0183883–e0183883. 9 indexed citations
8.
Zheng, Donghang, et al.. (2013). Serpins for Diagnosis and Therapy in Cancer. Cardiovascular & Haematological Disorders - Drug Targets. 13(2). 123–132. 26 indexed citations
9.
Munuswamy‐Ramanujam, Ganesh, Erbin Dai, Yuming Sun, et al.. (2007). Abstract 718: Mammalian Serine Protease Inhibitor (Serpin), Neuroserpin, Targets Thromblytic Proteases to Reduce Inflammation, Atherogenesis and T Helper Lymphocyte Activation. Circulation. 116.
10.
Richardson, Mary, Liying Liu, David Wong, et al.. (2007). Viral serpin, Serp-1, inhibits endogenous angiogenesis in the chicken chorioallantoic membrane model. Cardiovascular Pathology. 16(4). 191–202. 15 indexed citations
11.
Korol, Renée, et al.. (2007). Fluorescence spectroscopy and birefringence of molecular changes in maturing rat tail tendon. Journal of Biomedical Optics. 12(2). 24011–24011. 17 indexed citations
12.
Munuswamy‐Ramanujam, Ganesh, Kashif Aziz Khan, & Alexandra Lucas. (2006). Viral Anti-Inflammatory Reagents: The Potential for Treatment of Arthritic and Vasculitic Disorders. Endocrine Metabolic & Immune Disorders - Drug Targets. 6(4). 331–343. 4 indexed citations
13.
Lucas, Alexandra & Grant McFadden. (2004). Secreted Immunomodulatory Viral Proteins as Novel Biotherapeutics. The Journal of Immunology. 173(8). 4765–4774. 72 indexed citations
14.
Bédard, Eric L.R., Peter Kim, Jifu Jiang, et al.. (2003). CHEMOKINE-BINDING VIRAL PROTEIN M-T7 PREVENTS CHRONIC REJECTION IN RAT RENAL ALLOGRAFTS. Transplantation. 76(1). 249–252. 35 indexed citations
15.
Lucas, Alexandra, et al.. (2001). Apolipoprotein E: Possible Therapeutic Target for Atherosclerosis. PubMed. 1(2). 93–106. 24 indexed citations
16.
Pilarski, Linda M., Alexander Christov, P. N. Nation, et al.. (2001). Increased circulating monocyte activation in patients with unstable coronary syndromes. Journal of the American College of Cardiology. 38(5). 1340–1347. 41 indexed citations
17.
Hatton, Mark W.C., et al.. (2000). Metabolism and distribution of the virus-encoded serine proteinase inhibitor SERP-1 in healthy rabbits. Metabolism. 49(11). 1449–1452. 6 indexed citations
18.
Christov, Alexander, Erbin Dai, Liying Liu, et al.. (1999). Detection of transplant vasculopathy in a rat aortic allograft model by fluorescence spectroscopic optical analysis. Lasers in Surgery and Medicine. 24(5). 346–359. 3 indexed citations
19.
Lalani, Alshad S., et al.. (1999). Role of the Myxoma Virus Soluble CC-Chemokine Inhibitor Glycoprotein, M-T1, during Myxoma Virus Pathogenesis. Virology. 256(2). 233–245. 62 indexed citations
20.
Graham, Kathryn, Alshad S. Lalani, Joanne Macen, et al.. (1997). The T1/35kDa Family of Poxvirus-Secreted Proteins Bind Chemokines and Modulate Leukocyte Influx into Virus-Infected Tissues. Virology. 229(1). 12–24. 180 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026